Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (19413)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 24, 2021 (publication date) through Oct 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
2023 | Number of total visits
| Rank | Countries/Territories | Count | Percent |
| 1 | United States | 101 | 27.7% |
| 2 | Canada | 29 | 7.9% |
| 3 | China | 29 | 7.9% |
| 4 | Ireland | 28 | 7.7% |
| 5 | Netherlands | 26 | 7.1% |
| 6 | Japan | 15 | 4.1% |
| 7 | Hungary | 12 | 3.3% |
| 8 | France | 11 | 3% |
| 9 | Spain | 10 | 2.7% |
| 10 | Germany | 9 | 2.5% |
| 11 | Mexico | 9 | 2.5% |
| 12 | Korea, Republic of | 8 | 2.2% |
| 13 | India | 7 | 1.9% |
| 14 | Taiwan | 7 | 1.9% |
| 15 | United Kingdom | 7 | 1.9% |
| 16 | Israel | 5 | 1.4% |
| 17 | Poland | 5 | 1.4% |
| 18 | Sweden | 4 | 1.1% |
| 19 | Greece | 4 | 1.1% |
| 20 | Italy | 3 | 0.8% |
| 21 | Belgium | 3 | 0.8% |
| 22 | Sri Lanka | 3 | 0.8% |
| 23 | Singapore | 3 | 0.8% |
| 24 | Slovenia | 2 | 0.5% |
| 25 | South Africa | 2 | 0.5% |
| 26 | Austria | 2 | 0.5% |
| 27 | Malaysia | 2 | 0.5% |
| 28 | Brazil | 2 | 0.5% |
| 29 | Cyprus | 2 | 0.5% |
| 30 | Czech Republic | 2 | 0.5% |
| 31 | Egypt | 2 | 0.5% |
| 32 | Hong Kong | 2 | 0.5% |
| 33 | Syrian Arab Republic | 2 | 0.5% |
| 34 | Finland | 1 | 0.3% |
| 35 | Colombia | 1 | 0.3% |
| 36 | New Zealand | 1 | 0.3% |
| 37 | Lithuania | 1 | 0.3% |
| 38 | Jordan | 1 | 0.3% |
| 39 | Russia | 1 | 0.3% |
| 40 | Switzerland | 1 | 0.3% |